Singapore markets open in 5 hours 50 minutes

Atossa Therapeutics, Inc. (ATOS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.6700+0.0100 (+0.38%)
As of 3:06PM EDT. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 5352.01M
Enterprise value 3209.58M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)2.44
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 7-11.50

Trading information

Stock price history

Beta (5Y monthly) 2.25
52-week change 369.43%
S&P500 52-week change 339.86%
52-week high 39.8000
52-week low 30.8100
50-day moving average 33.2058
200-day moving average 33.6799

Share statistics

Avg vol (3-month) 36.4M
Avg vol (10-day) 33.52M
Shares outstanding 5126.62M
Implied shares outstanding 6N/A
Float 8126.6M
% held by insiders 10.04%
% held by institutions 131.42%
Shares short (29 Sep 2021) 422.28M
Short ratio (29 Sep 2021) 43.4
Short % of float (29 Sep 2021) 417.60%
Short % of shares outstanding (29 Sep 2021) 417.59%
Shares short (prior month 30 Aug 2021) 424.6M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 319 Apr 2018
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 319 Apr 2018

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-14.63%
Return on equity (ttm)-28.27%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -18.23M
Net income avi to common (ttm)-26.05M
Diluted EPS (ttm)-0.4320
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)142.43M
Total cash per share (mrq)1.12
Total debt (mrq)4.72k
Total debt/equity (mrq)0.00
Current ratio (mrq)81.19
Book value per share (mrq)1.14

Cash flow statement

Operating cash flow (ttm)-15.86M
Levered free cash flow (ttm)-9.03M